Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey

Objective This study describes acceptance and attitudes towards genetic cancer testing among German primary care patients.Design Cross-sectional survey.Setting Primary care.Participant Systematically recruited patients aged ≥18 years from six general practices in Mecklenburg-Western Pomerania partic...

Full description

Saved in:
Bibliographic Details
Main Authors: Ute Felbor, Jean-Francois Chenot, Susanne Wurm, Diana Guertler, Sabina Ulbricht, Ann-Kristin Reinhard
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:Family Medicine and Community Health
Online Access:https://fmch.bmj.com/content/13/3/e003395.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849706327848255488
author Ute Felbor
Jean-Francois Chenot
Susanne Wurm
Diana Guertler
Sabina Ulbricht
Ann-Kristin Reinhard
author_facet Ute Felbor
Jean-Francois Chenot
Susanne Wurm
Diana Guertler
Sabina Ulbricht
Ann-Kristin Reinhard
author_sort Ute Felbor
collection DOAJ
description Objective This study describes acceptance and attitudes towards genetic cancer testing among German primary care patients.Design Cross-sectional survey.Setting Primary care.Participant Systematically recruited patients aged ≥18 years from six general practices in Mecklenburg-Western Pomerania participated in an anonymous self-administered survey on familial cancer prevention (n=479 and 67.0% participation rate). Those with complete data were analysed (n=424; mean age 53.7, SD 16.6 years; men 34.4%). Linear regression analyses were used to examine potential disparities in general acceptance of genetic testing and attitudes towards genetic cancer testing according to sociodemographics and familial cancer knowledge.Result General acceptance of genetic testing was high, particularly among younger, higher-educated individuals and those with a family history of cancer and higher familial cancer knowledge. For example, 83.3% either agreed or strongly agreed that it should be available to anybody. The most important benefits of genetic cancer testing were to guide check-up frequency (81.4%), to inform medical decision-making (80.2%) and to understand children’s risk (75.2%). The most important concerns included the potential burden on the family (44.6%) and the belief that cancer cannot be prevented (39.2%). More favourable attitudes were found among younger, higher-educated individuals, those with a personal history of cancer and those with fewer children or no partner. For example, higher age was linked to lower benefit (regression coefficient (RC) −0.01, 95% CI −0.01 to −0.001) and higher concern ratings (RC 0.01, 95% CI 0.002 to 0.01). About a third (34.7%) rated not wanting to know about genetic alterations that increase their cancer risk as a (very) important reason against testing. Information avoidance was higher among older individuals (RC 0.02, 95% CI 0.01 to 0.02), women (RC 0.40, 95% CI 0.11 to 0.69), those with lower education (RC −0.64, 95% CI −0.91 to −0.36) and those with more children (RC 0.21, 95% CI 0.09 to 0.33).Conclusion Acceptance of genetic testing was high, but barriers remain, particularly among older adults, women, the less educated and those with more children. Targeted educational efforts to improve health literacy, emphasise the preventive potential of genetic testing and emotional support through genetic counselling are essential to overcome these barriers and promote informed decision-making.
format Article
id doaj-art-8b263b5d6bca44dd8b595d6a2ce36a41
institution DOAJ
issn 2305-6983
2009-8774
language English
publishDate 2025-07-01
publisher BMJ Publishing Group
record_format Article
series Family Medicine and Community Health
spelling doaj-art-8b263b5d6bca44dd8b595d6a2ce36a412025-08-20T03:16:14ZengBMJ Publishing GroupFamily Medicine and Community Health2305-69832009-87742025-07-0113310.1136/fmch-2025-003395Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional surveyUte Felbor0Jean-Francois Chenot1Susanne Wurm2Diana Guertler3Sabina Ulbricht4Ann-Kristin Reinhard5Department of Human Genetics, University Medicine Greifswald, Greifswald, GermanyDepartment of General Practice, Institute of Community Medicine, University Medicine Greifswald, Greifswald, GermanyDepartment of Prevention Research and Social Medicine, Institute of Community Medicine, University Medicine Greifswald, Greifswald, GermanyDepartment of Methods of Community Medicine, Institute of Community Medicine, University Medicine Greifswald, Greifswald, GermanyDepartment of SHIP/KEF, Institute of Community Medicine, University Medicine Greifswald, Greifswald, GermanyDepartment of Prevention Research and Social Medicine, Institute of Community Medicine, University Medicine Greifswald, Greifswald, GermanyObjective This study describes acceptance and attitudes towards genetic cancer testing among German primary care patients.Design Cross-sectional survey.Setting Primary care.Participant Systematically recruited patients aged ≥18 years from six general practices in Mecklenburg-Western Pomerania participated in an anonymous self-administered survey on familial cancer prevention (n=479 and 67.0% participation rate). Those with complete data were analysed (n=424; mean age 53.7, SD 16.6 years; men 34.4%). Linear regression analyses were used to examine potential disparities in general acceptance of genetic testing and attitudes towards genetic cancer testing according to sociodemographics and familial cancer knowledge.Result General acceptance of genetic testing was high, particularly among younger, higher-educated individuals and those with a family history of cancer and higher familial cancer knowledge. For example, 83.3% either agreed or strongly agreed that it should be available to anybody. The most important benefits of genetic cancer testing were to guide check-up frequency (81.4%), to inform medical decision-making (80.2%) and to understand children’s risk (75.2%). The most important concerns included the potential burden on the family (44.6%) and the belief that cancer cannot be prevented (39.2%). More favourable attitudes were found among younger, higher-educated individuals, those with a personal history of cancer and those with fewer children or no partner. For example, higher age was linked to lower benefit (regression coefficient (RC) −0.01, 95% CI −0.01 to −0.001) and higher concern ratings (RC 0.01, 95% CI 0.002 to 0.01). About a third (34.7%) rated not wanting to know about genetic alterations that increase their cancer risk as a (very) important reason against testing. Information avoidance was higher among older individuals (RC 0.02, 95% CI 0.01 to 0.02), women (RC 0.40, 95% CI 0.11 to 0.69), those with lower education (RC −0.64, 95% CI −0.91 to −0.36) and those with more children (RC 0.21, 95% CI 0.09 to 0.33).Conclusion Acceptance of genetic testing was high, but barriers remain, particularly among older adults, women, the less educated and those with more children. Targeted educational efforts to improve health literacy, emphasise the preventive potential of genetic testing and emotional support through genetic counselling are essential to overcome these barriers and promote informed decision-making.https://fmch.bmj.com/content/13/3/e003395.full
spellingShingle Ute Felbor
Jean-Francois Chenot
Susanne Wurm
Diana Guertler
Sabina Ulbricht
Ann-Kristin Reinhard
Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey
Family Medicine and Community Health
title Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey
title_full Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey
title_fullStr Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey
title_full_unstemmed Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey
title_short Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey
title_sort acceptance and attitudes towards genetic cancer testing among german general practice patients a cross sectional survey
url https://fmch.bmj.com/content/13/3/e003395.full
work_keys_str_mv AT utefelbor acceptanceandattitudestowardsgeneticcancertestingamonggermangeneralpracticepatientsacrosssectionalsurvey
AT jeanfrancoischenot acceptanceandattitudestowardsgeneticcancertestingamonggermangeneralpracticepatientsacrosssectionalsurvey
AT susannewurm acceptanceandattitudestowardsgeneticcancertestingamonggermangeneralpracticepatientsacrosssectionalsurvey
AT dianaguertler acceptanceandattitudestowardsgeneticcancertestingamonggermangeneralpracticepatientsacrosssectionalsurvey
AT sabinaulbricht acceptanceandattitudestowardsgeneticcancertestingamonggermangeneralpracticepatientsacrosssectionalsurvey
AT annkristinreinhard acceptanceandattitudestowardsgeneticcancertestingamonggermangeneralpracticepatientsacrosssectionalsurvey